Community Health Systems, Inc. (CYH)

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Community Health Systems, Inc. (“Community Health” or “the Company”) (NYSE: CYH). Investors who purchased Community Health securities are encouraged to obtain additional information and assist the investigation.

The investigation concerns whether Community Health has violated federal securities laws.

Investigation Details:

On February 21, 2024, Community Health disclosed in its Annual Report for 2023 that it was under investigation by the U.S. Department of Justice (“DOJ”). The Company revealed that it had received a Civil Investigative Demand from the DOJ on January 11, 2024, seeking “documents and information relating to a variety of subjects, including practices and procedures related to utilization review, inpatient admissions and inpatient dialysis at [the Company’s] hospitals.” On this news, Community Health’s stock price fell $1.14 per share, or 28.2%, to close at $2.90 per share on February 21, 2024.

What’s Next?

If you are aware of any facts relating to this investigation or purchased Community Health securities, you can assist this investigation. You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.

There is No Cost to You

We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman:

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Attorney advertising. Prior results do not guarantee similar outcomes.


Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Nathanson

332-239-2660 | [email protected]